Skip to content

13F-HR filed by Eversept Partners, LP

Eversept Partners, LP filed this 13F-HR for the quarter ended 2018-06-30, filed 2018-08-14, with 73 holding rows worth $209,634,000.

Accession
0001697013-18-000009
Filed
2018-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2018

A holdings report, 73 entries on the cover page, a total value of $209,634,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $209,634,000 with VALUE read as thousands by filing date, 13F file number 028-18369. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
QUALITY CARE PPTYS INC747545101COM1,074,080$23,103,000thousands by filing date
R1 RCM INC749397105COM1,808,076$15,694,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM226,902$15,327,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW468,581$13,809,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR252,584$10,315,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR212,972$8,521,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM84,257$7,937,000thousands by filing date
TELIGENT INC NEW87960W104COM2,112,098$7,308,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM43,401$6,794,000thousands by filing date
ZOGENIX INC.98978L204Common Stock150,845$6,667,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock63,493$6,253,000thousands by filing date
ENSIGN GROUP INC29358P101COM166,080$5,956,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM34,822$5,918,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW134,151$5,849,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM40,000$5,287,000thousands by filing date
NEVRO CORP64157F103COM47,279$3,775,000thousands by filing date
SPDR S&P 500 ETF TR78462F953PUT300$3,696,000thousands by filing dateput
Abbott Laboratories002824100COM45,900$2,799,000thousands by filing date
ATHENAHEALTH INC04685W103COMMON STOCK16,000$2,546,000thousands by filing date
TESARO INC881569107COM52,523$2,336,000thousands by filing date
ANAPTYSBIO INC032724106COM32,634$2,318,000thousands by filing date
ABIOMED INC003654100COM5,594$2,288,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM98,395$2,165,000thousands by filing date
ARQULE INC04269E107COM374,320$2,070,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR24,384$2,020,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR30,054$1,999,000thousands by filing date
INVACARE CORP461203101COMMON STOCK99,902$1,858,000thousands by filing date
CARETRUST REIT INC COM14174T107REIT101,264$1,711,000thousands by filing date
MEDICINES CO584688105COM39,317$1,443,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM107,096$1,437,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW460,000$1,421,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK23,924$1,415,000thousands by filing date
TANDEM DIABETES CARE INC875372203COM NEW61,300$1,350,000thousands by filing date
HAEMONETICS CORP MASS COM405024100Stock14,646$1,313,000thousands by filing date
IMMUNOMEDICS INC452907108COM55,000$1,302,000thousands by filing date
MYOKARDIA INC62857M105COM25,950$1,288,000thousands by filing date
MADRIGAL PHARMACEUTICALS INC COM558868105Stock4,500$1,259,000thousands by filing date
EHEALTH INC28238P109COM56,546$1,250,000thousands by filing date
ZOGENIX INC98978L954PUT1,233$1,201,000thousands by filing dateput
Elevance Health, Inc.036752103COM5,000$1,190,000thousands by filing date
AKORN INC009728106COM70,000$1,161,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock80,000$1,052,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM85,000$1,041,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock8,000$986,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock148,959$854,000thousands by filing date
CELLECTIS ADS15117K103COM30,000$849,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock48,412$812,000thousands by filing date
VERICEL CORP92346J108COM74,837$726,000thousands by filing date
Arbutus Biopharma Corp03879J100Common Shares, without par value97,495$712,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM55,000$704,000thousands by filing date
EPIZYME INC29428V104COM47,449$643,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK18,029$640,000thousands by filing date
AFFIMED N VN01045108COM386,862$638,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM13,800$624,000thousands by filing date
FOAMIX PHARMACEUTICALS LTDM46135105SHS107,500$539,000thousands by filing date
MELINTA THERAPEUTICS INC58549G100COM76,837$488,000thousands by filing date
INTRICON CORP46121H109COM12,000$484,000thousands by filing date
MODEL N INC607525102COM22,461$418,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158201COM NEW27,000$412,000thousands by filing date
OPHTHOTECH CORP683745103COM149,100$407,000thousands by filing date
AVID BIOSERVICES INC05368M106COM100,402$394,000thousands by filing date
SEASPINE HLDGS CORP81255T108COM30,899$390,000thousands by filing date
QUALITY CARE PROPERTIES747545901COM NEW200$387,000thousands by filing datecall
CELYAD ONCOLOGY SA151205200ADR12,840$382,000thousands by filing date
DECIPHERA PHARMACEUTICALS IN24344T101COM9,536$375,000thousands by filing date
IRADIMED CORP46266A109COMMON STOCK17,608$365,000thousands by filing date
MAGELLAN HEALTH SERVICES INC559079207COM NEW3,000$288,000thousands by filing date
ZOGENIX INC98978L904CALL100$199,000thousands by filing datecall
DERMIRA INC24983L104COM20,018$184,000thousands by filing date
CONFORMIS INC20717E101COM126,851$159,000thousands by filing date
GALMED PHARMACEUTICALS LTDM47238106SHS10,000$119,000thousands by filing date
QUALITY CARE PROPERTIES ORD747545951PUT18$12,000thousands by filing dateput
CELGENE CORP151020112RIGHT 12/31/20306,000$2,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001697013-18-000009this filing2018-08-14acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000008 base2023-11-08acceptance time not in the bulk data set